End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.8 TWD | +0.46% | +0.57% | -9.50% |
05-06 | Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
TWD in Million | 2023 | Weight | Delta |
---|---|---|---|
Biomedical
103.6
%
| 645 | 103.6 % | - |
Adjustments and Write-offs
-6.9
%
| -43 | -6.9 % | - |
Consumer
3.3
%
| 20 | 3.3 % | - |
Sales per region
TWD in Million | 2023 | Weight | Delta |
---|---|---|---|
Taiwan
44.3
%
| 276 | 44.3 % | - |
America
32.0
%
| 199 | 32.0 % | - |
Asia
15.4
%
| 96 | 15.4 % | - |
Europe
4.5
%
| 28 | 4.5 % | - |
Other
3.8
%
| 24 | 3.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jing Ting Chen
CEO | Chief Executive Officer | - | 21-11-02 |
Ruei Yi Wu
DFI | Director of Finance/CFO | - | 23-03-21 |
Yi Hua Yu
DFI | Director of Finance/CFO | - | 18-06-20 |
Cian Tian Huang
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yong Xiang Lin
CHM | Chairman | - | 21-07-11 |
Xiu Yuan Li
BRD | Director/Board Member | - | 15-06-21 |
Zhen Zhen Fu
BRD | Director/Board Member | - | 21-07-11 |
Jing Ting Chen
CEO | Chief Executive Officer | - | 21-11-02 |
Song Yuan Liao
BRD | Director/Board Member | - | 21-07-11 |
Shih Ming Li
BRD | Director/Board Member | - | 21-07-11 |
Zhong Ming Zeng
BRD | Director/Board Member | - | 21-07-11 |
Tsong Jieh Chiou
BRD | Director/Board Member | - | 22-06-20 |
Shih Ming Lai
BRD | Director/Board Member | - | 22-06-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 88,957,115 | 49,177,115 ( 55.28 %) | 0 | 55.28 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-9.50% | 121M | |
+20.12% | 20.76B | |
0.00% | 19.32B | |
+11.99% | 12.59B | |
-15.62% | 9.03B | |
+23.93% | 8.1B | |
+9.36% | 5.93B | |
-3.97% | 4.46B | |
-17.36% | 3.81B | |
-5.16% | 3.59B |
- Stock Market
- Equities
- 1783 Stock
- Company Maxigen Biotech Inc.